SENATE BILL REPORT
SB 5729
As of February 13, 2023
Title: An act relating to extending the expiration date on the cost-sharing cap for insulin.
Brief Description: Extending the expiration date on the cost-sharing cap for insulin.
Sponsors: Senators Keiser, Cleveland, Hasegawa, Hunt, Kuderer, Nguyen, Shewmake, Stanford, Valdez and Wilson, C..
Brief History:
Committee Activity: Health & Long Term Care: 2/14/23.
Brief Summary of Bill
  • Extends the expiration date on the $35 out-of-pocket limit for a 30-day supply of insulin to January 1, 2025.
SENATE COMMITTEE ON HEALTH & LONG TERM CARE
Staff: Greg Attanasio (786-7410)
Background:

In 2020, the Legislature directed health plans, beginning January 1, 2021, to limit an enrollee's out-of-pocket expenses for insulin to $100 for a 30-day supply until January 1, 2023. In 2022, the Legislature amended the statute to reduce the limit on out-of-pocket expenses for a 30-day supply of insulin to $35 until January 1, 2024.
Summary of Bill:

The expiration date limiting out-of-pocket expenses to $35 for a 30-day supply of insulin is extended to January 1, 2025. 
Appropriation: None.
Fiscal Note: Requested on February 10, 2023.
Creates Committee/Commission/Task Force that includes Legislative members: No.
Effective Date: Ninety days after adjournment of session in which bill is passed.